Shaping the Future
of Healthcare

Going beyond standard generics, we use innovation and expertise to develop even the most complex medicines for patient healthcare – from biosimilars and complex injectables to respiratory and specialty generics.

  • slider-dummy-1
  • image2
  • image3
  • slider-dummy-4

Sandoz is a world leader in generic pharmaceuticals, finding innovative ways to making medicines affordable and accessible to more than 90 percent of the world’s population.

Learn more about our company
Visions and Values


FDA accepts Sandoz application for biosimilar filgrastim

Holzkirchen, July 24, 2014

Sandoz, a Novartis Group company, announced today that the US Food and Drug Administration (FDA) has accepted its Biologics License Application for filgrastim.


Our people are our greatest resource. We are always looking for new colleagues to share in our commitment to make the world a healthier place.

Learn more about a career at Sandoz

Watch our Sandoz TV video series to discover more about the world of Sandoz and generics.

Visit our multimedia gallery to watch the latest episode


We have collected the most important and frequently asked questions about our business.

Read more
Get Adobe Flash player